Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (480)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Perry, E. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, E. K
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 42:63-69 (1986)
© 1986 The British Council

research-article

THE CHOLINERGIC HYPOTHESIS—TEN YEARS ON

Elaine K Perry

Department of Neuropathology, Regional Neurological Centre Newcastle General Hospital, Newcastle upon Tyne

Abstract

The cholinergic hypothesis of Alzheimer's disease originally postulated a connection between some of the cognitive impaiments of this disorder, particularly memory, and a disturbance in cerebral cholinergic neurotransmission. A decade of neurochemical, anatomical, pathological and psychopharmacological research has since reinforced and refined the hypothesis. Current evidence suggests a critical role for cortical cholinergic projections, originating in the basal forebrain, in the memory component (possibly via activation of encoding mechanisms) of both Alzheimer and Parkinson types of dementia. In more advanced stages of Alzheimer's disease, the involvement of other transmitters extends the search for potential long-term therapy beyound the cholinergic system. Nevertheless, the cholinergic hypothesis still merits investigation today with a view to obtaining more precise information on the role of the human cerebral cholinergic system memory and, with the advent of novel approaches to cholinergic therapy, to improving the management of at least mildly demented patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
H.-W. Klafki, M. Staufenbiel, J. Kornhuber, and J. Wiltfang
Therapeutic approaches to Alzheimer's disease
Brain, November 1, 2006; 129(11): 2840 - 2855.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. Raiteri
Functional pharmacology in human brain.
Pharmacol. Rev., June 1, 2006; 58(2): 162 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
L. Zhang, F.-M. Zhou, and J. A. Dani
Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine Release
Mol. Pharmacol., September 1, 2004; 66(3): 538 - 544.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. Trabace, T. Cassano, L. Steardo, C. Pietra, G. Villetti, K. M. Kendrick, and V. Cuomo
Biochemical and Neurobehavioral Profile of CHF2819, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer's Disease
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 187 - 194.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
A. L. Markowska
Sex Dimorphisms in the Rate of Age-Related Decline in Spatial Memory: Relevance to Alterations in the Estrous Cycle
J. Neurosci., September 15, 1999; 19(18): 8122 - 8133.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
D. S. Baskin, J. L. Browning, F. J. Pirozzolo, S. Korporaal, J. A. Baskin, and S. H. Appel
Brain Choline Acetyltransferase and Mental Function in Alzheimer Disease
Arch Neurol, September 1, 1999; 56(9): 1121 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
L. J. Fitten, F. Ortiz, D. W. Siembieda, J. O'Neill, E. Halgren, and A. Fisher
Reduction of Motoric Agitation and Restlessness by AF102B and Tacrine in the Macaque
J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 79 - 85.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Kar, D. Seto, S. Dore, U.-K. Hanisch, and R. Quirion
Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation
PNAS, December 9, 1997; 94(25): 14054 - 14059.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Köppen, J. Klein, C. Erb, and K. Löffelholz
Acetylcholine Release and Choline Availability in Rat Hippocampus: Effects of Exogenous Choline and Nicotinamide
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1139 - 1145.
[Abstract] [Full Text]

Home page
 BMJHome page
C Holmes, O Fortenza, J Powell, S Lovestone, R. Tobiansky, M. Blanchard, P W Bentham, S E Goh, E M Gregg, P Madeley, et al.
Do neuroleptic drugs hasten cognitive decline in dementia?
BMJ, May 10, 1997; 314(7091): 1411 - 1411.
[Full Text]

Home page
 J PsychopharmacolHome page
N.H.P. Allen and A. Burns
The treatment of Alzheimer's disease
J Psychopharmacol, January 1, 1995; 9(1): 43 - 56.
[PDF]

Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
K. M. Kolasa, C. Schmidt, and J. A. Bartlett
Feeding Alzheimer's patients
American Journal of Alzheimer's Disease and Other Dementias, May 1, 1989; 4(3): 17 - 20.
[PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.